Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease

Journal of Neuroimaging

Volumn 12, Issue 4, 2002, Pages 368-370

  Sener, R N ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Brain; Diffusion weighted magnetic resonance (MR); Maple syrup urine disease

Indexed keywords

CARBOXYLYASE; LEUCINE DECARBOXYLASE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DENTATE NUCLEUS; DIFFUSION COEFFICIENT; GLOBUS PALLIDUS; HUMAN; MALE; MAPLE SYRUP URINE DISEASE; MESENCEPHALON; MYELIN DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PONS; SCHOOL CHILD;

EID: 0036785111     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2002.tb00146.x     Document Type: Article

References (14)

1. Brismar J, Aqeel A, Brismar G, Coates R, Gascon G, Ozand P. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. Am J Neuroradiol 1990;11:1219-1228.
2. Taccone A, Schiaffino MC, Cerone R, Fondelli MP, Romano C. Computed tomography in maple syrup urine disease. Eur J Radiol 1992;14:207-212.
3. Muller K, Kahn T, Wendel U. Is demyelination a feature of maple syrup urine disease? Pediatr Neurol 1993;9:375-382.
4. Li PH, Ma JS, Chi CS, Mak SC. Intermittent form of maple syrup urine disease: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1997;38:468-471.
5. Ishikawa A, Okayasu T, Miyasaka K, Fukushima N, Takase A, Wagatsuma Y. A mild variant case of maple syrup urine disease. No To Hattatsu 1991;23:71-74.
6. Uziel G, Savoiardo M, Nardocci N. CT and MRI in maple syrup urine disease Neurology 1988;38:486-488.
7. Felber SR, Sperl W, Chemelli A, Murr C, Wendel U. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol 1993;33:396-401.
8. van der Knaap MS, Valk J. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin, Germany: Springer; 1995.
9. Phillips MD, McGraw P, Lowe MJ, Mathews VP, Hainline BE. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. Am J Neuroradiol 2001;22:1583-1586.
10. Sener RN. Tuberous sclerosis: diffusion MRI findings in the brain. Eur Radiol 2002;12:138-143.
11. Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR. Decreased diffusion in central pontine myelinolysis. Am J Neuroradiol 2001;22:1476-1479.
12. Morriss MC, Zimmerman RA, Bilaniuk LT, Hunter JV, Haselgrove JC. Changes in brain water diffusion during childhood. Neuroradiology 1999;41:929-934.
13. Provenzale JM, Petrella JR, Cruz LCH Jr, Wong JC, Engelter S, Barboriak DP. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. Am J Neuroradiol 2001;22:1455-1461.
14. Sener RN. Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain, and a classification of brain disorders based on ADC values. Comput Med Imaging Graph 2001;25:299-326.